Recent Analysts’ Ratings Updates for Synopsys (SNPS)

Several brokerages have updated their recommendations and price targets on shares of Synopsys (NASDAQ: SNPS) in the last few weeks:

• 8/27/2026 – Synopsys was given a new $570.00 price target by UBS Group AG.
• 8/27/2026 – Synopsys had its price target lowered by Mizuho from $600.00 to $550.00. They now have an “outperform” rating on the stock.
• 8/27/2026 – Synopsys was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $560.00 price target on the stock, up from $558.00.
• 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co.. They now have a $570.00 price target on the stock.
• 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $580.00 price target on the stock.
• 8/25/2026 – Synopsys had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $575.00 price target on the stock.
• 8/21/2026 – Synopsys was downgraded by Zacks Research from “strong-buy” to “hold”.
• 8/19/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co..
• 8/19/2026 – Synopsys had its price target lowered by Morgan Stanley from $525.00 to $500.00. They now have an “equal weight” rating on the stock.
• 8/19/2026 – Synopsys had its “overweight” rating reaffirmed by KeyCorp.
• 8/11/2026 – Synopsys had its price target lowered by Wells Fargo & Company from $535.00 to $450.00. They now have an “equal weight” rating on the stock.
• 7/15/2026 – Synopsys is now covered by Benchmark Co.. They set a “buy” rating and a $570.00 price target on the stock.
• 7/15/2026 – Synopsys was upgraded by Benchmark Co. to “strong-buy”.
• 6/30/2026 – Synopsys was upgraded by Zacks Research from “hold” to “strong-buy”.

Insiders Place Their Bets

In other news, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is owned by corporate insiders.

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.